Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenqiu Zhang

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Obesity Surgery|July 22, 2021
Lisdexamfetamine Pharmacokinetic Comparison Between Patients Who Underwent Roux-en-Y Gastric Bypass and Nonsurgical ControlsKristine J Steffen, Afroz S Mohammad, James L Roerig, et al.
Molecular Cancer Therapeutics|October 13, 2023
Delivery versus Potency in Treating Brain Tumors: BI-907828, a MDM2-p53 Antagonist with Limited BBB Penetration but Significant In Vivo Efficacy in GlioblastomaWenjuan Zhang, Rachael A Vaubel, Ju-Hee Oh, et al.
Frontiers in Pharmacology|August 11, 2018
Optimal Regimens and Cutoff Evaluation of Tildipirosin Against <i>Pasteurella multocida</i>Zhixin Lei, Qianying Liu, Yi Qi, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 10, 2024
Preclinical Systemic Pharmacokinetics, Dose Proportionality, and Central Nervous System Distribution of the ATM Inhibitor WSD0628, a Novel Radiosensitizer for the Treatment of Brain TumorsSneha Rathi, Ju-Hee Oh, Wenjuan Zhang, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 16, 2024
Factors Influencing the Central Nervous System (CNS) Distribution of the Ataxia Telangiectasia Mutated and Rad3-Related Inhibitor Elimusertib (BAY1895344): Implications for the Treatment of CNS TumorsSneha Rathi, Ann C Mladek, Ju-Hee Oh, et al.
Neuro-Oncology|September 8, 2025
Window of opportunity evaluation of blood-brain barrier permeability heterogeneity within and across high-grade glioma patientsJu-Hee Oh, Sarah K Reed, Cecile Riviere-Cazaux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2025
Preclinical Modeling of Navtemadlin Pharmacokinetics, Pharmacodynamics, and Efficacy in IDH-Wild-type GlioblastomaRachael A Vaubel, Wenjuan Zhang, Ju-Hee Oh, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Obesity Surgery|July 22, 2021
Lisdexamfetamine Pharmacokinetic Comparison Between Patients Who Underwent Roux-en-Y Gastric Bypass and Nonsurgical ControlsKristine J Steffen, Afroz S Mohammad, James L Roerig, et al.
Molecular Cancer Therapeutics|October 13, 2023
Delivery versus Potency in Treating Brain Tumors: BI-907828, a MDM2-p53 Antagonist with Limited BBB Penetration but Significant In Vivo Efficacy in GlioblastomaWenjuan Zhang, Rachael A Vaubel, Ju-Hee Oh, et al.
Frontiers in Pharmacology|August 11, 2018
Optimal Regimens and Cutoff Evaluation of Tildipirosin Against <i>Pasteurella multocida</i>Zhixin Lei, Qianying Liu, Yi Qi, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 10, 2024
Preclinical Systemic Pharmacokinetics, Dose Proportionality, and Central Nervous System Distribution of the ATM Inhibitor WSD0628, a Novel Radiosensitizer for the Treatment of Brain TumorsSneha Rathi, Ju-Hee Oh, Wenjuan Zhang, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 16, 2024
Factors Influencing the Central Nervous System (CNS) Distribution of the Ataxia Telangiectasia Mutated and Rad3-Related Inhibitor Elimusertib (BAY1895344): Implications for the Treatment of CNS TumorsSneha Rathi, Ann C Mladek, Ju-Hee Oh, et al.
Neuro-Oncology|September 8, 2025
Window of opportunity evaluation of blood-brain barrier permeability heterogeneity within and across high-grade glioma patientsJu-Hee Oh, Sarah K Reed, Cecile Riviere-Cazaux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2025
Preclinical Modeling of Navtemadlin Pharmacokinetics, Pharmacodynamics, and Efficacy in IDH-Wild-type GlioblastomaRachael A Vaubel, Wenjuan Zhang, Ju-Hee Oh, et al.
Pageof 4